The Global Biopsy Devices Market size is expected to reach $3 billion by 2028, rising at a market growth of 7.5% CAGR during the forecast period.
The biopsy is a medical examination that is mainly used by surgeons, interventional radiologists, or interventional cardiologists. It involves the removal of model cells or tissues for testing the existence or degree of disease. After the removal of tissue, it is fixed, implanted, segmented, stained, and mounted, which is then analysed chemically by a pathologist.
Excisional biopsy is a process where a completely swollen area or doubtful part is taken out. Whereas, when a part of irregular tissue is taken out without removing the complete lesion or tumour, it is called an incisional biopsy or core biopsy.
Most biopsies are performed to know about probable cancerous or inflammatory conditions. Biopsy devices are used to inspect disorders by taking out a tissue from the affected place or organs with the help of the biopsy process while managing diagnostic examination. The use of every biopsy device is different and depends on the type of organ for which it is done.
Common biopsy devices may be used together with advanced imaging technologies like a stereotactic-guided biopsy, MRI-guided biopsy, CT scan, ultrasound-guided biopsy, and others to execute biopsy with precision and least invasiveness.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
The biopsy is a medical examination that is mainly used by surgeons, interventional radiologists, or interventional cardiologists. It involves the removal of model cells or tissues for testing the existence or degree of disease. After the removal of tissue, it is fixed, implanted, segmented, stained, and mounted, which is then analysed chemically by a pathologist.
Excisional biopsy is a process where a completely swollen area or doubtful part is taken out. Whereas, when a part of irregular tissue is taken out without removing the complete lesion or tumour, it is called an incisional biopsy or core biopsy.
Most biopsies are performed to know about probable cancerous or inflammatory conditions. Biopsy devices are used to inspect disorders by taking out a tissue from the affected place or organs with the help of the biopsy process while managing diagnostic examination. The use of every biopsy device is different and depends on the type of organ for which it is done.
Common biopsy devices may be used together with advanced imaging technologies like a stereotactic-guided biopsy, MRI-guided biopsy, CT scan, ultrasound-guided biopsy, and others to execute biopsy with precision and least invasiveness.
COVID-19 Impact Analysis
The COVID-19 pandemic severely impacted the biopsy devices market. During this period, the market experienced a number of disruptions, including the temporary shutdown of many industrial processes. This restrained commercial expansion, disrupted supply chain operations, and affected overall manufacturing and sales, and hence hampered the development of the healthcare industry. As a consequence, widespread cancellations of specialized treatments took place globally.Market Growth Factors
Increased Demand For Cancer Treatment
As per World Health Organization, the cancer is the foremost reason for death all over the world, accounting for almost 10 million demises in 2020, or approximately one in six deaths. The most common cases of cancers are breast, colon & rectum, lung, and prostate cancers. About one-third of people who die from cancer are due to tobacco, alcohol consumption, high body mass index, low fruit & vegetable consumption, and absence of bodily movement.Growth Of Healthcare Infrastructure
A significant factor supporting the expansion of the biopsy device market is expanding healthcare infrastructure. This is the result of the growing number and size of investments in the healthcare sector all over the globe. In addition, it is predicted that more developing economies are demanding high-quality healthcare facilities as they are supported by high spendable incomes. This factor is predicted to offer growth opportunities to the market players entering the biopsy device market.Market Restraining Factors
Alternatives To Biopsy Are Preferred More
There are some techniques that are chosen over biopsy. Patients choose these alternatives for cancer diagnosis because they are more efficient in terms of time, money, and technology. Confocal microscopy further assists the effectiveness of diagnostic procedures by providing instantly readable, high-resolution digital images. This technique has ability to access practically any part of the body with simple devices. Some tests are available that could detect the enzymes that prostate cancer produces to determine whether cancer is present and how aggressive or quickly it might be growing. This may negatively affect the biopsy device market.Product Outlook
Based on the product, the biopsy devices market is segmented into needle-based biopsy guns, biopsy guidance systems, biopsy needles, biopsy forceps and others. In 2021, the needle-based biopsy guns segment dominated the biopsy devices market with the maximum revenue share. The rising demand for these guns to obtain trials from soft tissues of internal body parts such as breasts, kidneys, and lungs is expected to support the growth of the overall market in this segment during projected period. The critical factor for the rise of needle-based biopsy guns is the growing necessity for quick and tender obtaining of cell trials for biopsy.
End-user Outlook
Based on the end user, the biopsy device market is categorized into hospitals, diagnostic imaging centers, and others. The diagnostic center segment procured a prominent revenue share in the biopsy device market in 2021. These centers are specially established for diagnosis purposes. People with high-income levels usually prefer getting diagnosed in such centers. In addition, the skilled personnel and use of the latest medical devices are promoting these centers. As a result of a high number of patients undergoing diagnosis in such centers, the market is predicted to grow in this segment during the projection period.Regional Outlook
Region-wise, the biopsy devices market, is analysed across North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region recorded the maximum revenue share in the biopsy devices market. Owing to recognized market players in this region, the demand for biopsy devices would further expand. In addition, high market infiltration taxes of technically innovative devices, for example, vacuum-assisted biopsy systems, and a quick rise in demand for not reusable devices are likely to support growth in the local markets.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
Scope of the Study
By Product
- Needle-based Biopsy Guns
- Vacuum-assisted Biopsy (VAB) Devices
- Fine Needle Aspiration Biopsy (FNAB) Devices
- Core Needle Biopsy (CNB) Devices
- Biopsy Guidance Systems
- Manual
- Robotic
- Biopsy Needles
- Disposable
- Reusable
- Biopsy Forceps
- Others
By End-user
- Hospitals
- Diagnostic & Imaging Center
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Hologic, Inc.
- Fujifilm Holdings Corporation
- B.Braun Melsungen AG
- Danaher Corporation
- ConMed Corporation
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Argon Medical Devices, Inc.
- Cook Medical, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Biopsy Devices Market, by Product
1.4.2 Global Biopsy Devices Market, by End User
1.4.3 Global Biopsy Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition &Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Biopsy Devices Market by Product
3.1 Global Needle-based Biopsy Guns Market by Region
3.2 Global Biopsy Devices Market by Needle-based Biopsy Guns Type
3.2.1 Global Vacuum-assisted Biopsy (VAB) Devices Market by Region
3.2.2 Global Fine Needle Aspiration Biopsy (FNAB) Devices Market by Region
3.2.3 Global Core Needle Biopsy (CNB) Devices Market by Region
3.3 Global Biopsy Guidance Systems Market by Region
3.4 Global Biopsy Devices Market by Biopsy Guidance Systems Type
3.4.1 Global Manual Market by Region
3.4.2 Global Robotic Market by Region
3.5 Global Biopsy Needles Market by Region
3.6 Global Biopsy Devices Market by Biopsy Needles Type
3.6.1 Global Disposable Market by Region
3.6.2 Global Reusable Market by Region
3.7 Global Biopsy Forceps Market by Region
3.8 Global Others Market by Region
Chapter 4. Global Biopsy Devices Market by End User
4.1 Global Hospitals Market by Region
4.2 Global Diagnostic & Imaging Center Market by Region
4.3 Global Others Market by Region
Chapter 5. Global Biopsy Devices Market by Region
5.1 North America Biopsy Devices Market
5.1.1 North America Biopsy Devices Market by Product
5.1.1.1 North America Needle-based Biopsy Guns Market by Country
5.1.1.2 North America Biopsy Devices Market by Needle-based Biopsy Guns Type
5.1.1.2.1 North America Vacuum-assisted Biopsy (VAB) Devices Market by Country
5.1.1.2.2 North America Fine Needle Aspiration Biopsy (FNAB) Devices Market by Country
5.1.1.2.3 North America Core Needle Biopsy (CNB) Devices Market by Country
5.1.1.3 North America Biopsy Guidance Systems Market by Country
5.1.1.4 North America Biopsy Devices Market by Biopsy Guidance Systems Type
5.1.1.4.1 North America Manual Market by Country
5.1.1.4.2 North America Robotic Market by Country
5.1.1.5 North America Biopsy Needles Market by Country
5.1.1.6 North America Biopsy Devices Market by Biopsy Needles Type
5.1.1.6.1 North America Disposable Market by Country
5.1.1.6.2 North America Reusable Market by Country
5.1.1.7 North America Biopsy Forceps Market by Country
5.1.1.8 North America Others Market by Country
5.1.2 North America Biopsy Devices Market by End User
5.1.2.1 North America Hospitals Market by Country
5.1.2.2 North America Diagnostic & Imaging Center Market by Country
5.1.2.3 North America Others Market by Country
5.1.3 North America Biopsy Devices Market by Country
5.1.3.1 US Biopsy Devices Market
5.1.3.1.1 US Biopsy Devices Market by Product
5.1.3.1.1.1 US Biopsy Devices Market by Needle-based Biopsy Guns Type
5.1.3.1.1.2 US Biopsy Devices Market by Biopsy Guidance Systems Type
5.1.3.1.1.3 US Biopsy Devices Market by Biopsy Needles Type
5.1.3.1.2 US Biopsy Devices Market by End User
5.1.3.2 Canada Biopsy Devices Market
5.1.3.2.1 Canada Biopsy Devices Market by Product
5.1.3.2.1.1 Canada Biopsy Devices Market by Needle-based Biopsy Guns Type
5.1.3.2.1.2 Canada Biopsy Devices Market by Biopsy Guidance Systems Type
5.1.3.2.1.3 Canada Biopsy Devices Market by Biopsy Needles Type
5.1.3.2.2 Canada Biopsy Devices Market by End User
5.1.3.3 Mexico Biopsy Devices Market
5.1.3.3.1 Mexico Biopsy Devices Market by Product
5.1.3.3.1.1 Mexico Biopsy Devices Market by Needle-based Biopsy Guns Type
5.1.3.3.1.2 Mexico Biopsy Devices Market by Biopsy Guidance Systems Type
5.1.3.3.1.3 Mexico Biopsy Devices Market by Biopsy Needles Type
5.1.3.3.2 Mexico Biopsy Devices Market by End User
5.1.3.4 Rest of North America Biopsy Devices Market
5.1.3.4.1 Rest of North America Biopsy Devices Market by Product
5.1.3.4.1.1 Rest of North America Biopsy Devices Market by Needle-based Biopsy Guns Type
5.1.3.4.1.2 Rest of North America Biopsy Devices Market by Biopsy Guidance Systems Type
5.1.3.4.1.3 Rest of North America Biopsy Devices Market by Biopsy Needles Type
5.1.3.4.2 Rest of North America Biopsy Devices Market by End User
5.2 Europe Biopsy Devices Market
5.2.1 Europe Biopsy Devices Market by Product
5.2.1.1 Europe Needle-based Biopsy Guns Market by Country
5.2.1.2 Europe Biopsy Devices Market by Needle-based Biopsy Guns Type
5.2.1.2.1 Europe Vacuum-assisted Biopsy (VAB) Devices Market by Country
5.2.1.2.2 Europe Fine Needle Aspiration Biopsy (FNAB) Devices Market by Country
5.2.1.2.3 Europe Core Needle Biopsy (CNB) Devices Market by Country
5.2.1.3 Europe Biopsy Guidance Systems Market by Country
5.2.1.4 Europe Biopsy Devices Market by Biopsy Guidance Systems Type
5.2.1.4.1 Europe Manual Market by Country
5.2.1.4.2 Europe Robotic Market by Country
5.2.1.5 Europe Biopsy Needles Market by Country
5.2.1.6 Europe Biopsy Devices Market by Biopsy Needles Type
5.2.1.6.1 Europe Disposable Market by Country
5.2.1.6.2 Europe Reusable Market by Country
5.2.1.7 Europe Biopsy Forceps Market by Country
5.2.1.8 Europe Others Market by Country
5.2.2 Europe Biopsy Devices Market by End User
5.2.2.1 Europe Hospitals Market by Country
5.2.2.2 Europe Diagnostic & Imaging Center Market by Country
5.2.2.3 Europe Others Market by Country
5.2.3 Europe Biopsy Devices Market by Country
5.2.3.1 Germany Biopsy Devices Market
5.2.3.1.1 Germany Biopsy Devices Market by Product
5.2.3.1.1.1 Germany Biopsy Devices Market by Needle-based Biopsy Guns Type
5.2.3.1.1.2 Germany Biopsy Devices Market by Biopsy Guidance Systems Type
5.2.3.1.1.3 Germany Biopsy Devices Market by Biopsy Needles Type
5.2.3.1.2 Germany Biopsy Devices Market by End User
5.2.3.2 UK Biopsy Devices Market
5.2.3.2.1 UK Biopsy Devices Market by Product
5.2.3.2.1.1 UK Biopsy Devices Market by Needle-based Biopsy Guns Type
5.2.3.2.1.2 UK Biopsy Devices Market by Biopsy Guidance Systems Type
5.2.3.2.1.3 UK Biopsy Devices Market by Biopsy Needles Type
5.2.3.2.2 UK Biopsy Devices Market by End User
5.2.3.3 France Biopsy Devices Market
5.2.3.3.1 France Biopsy Devices Market by Product
5.2.3.3.1.1 France Biopsy Devices Market by Needle-based Biopsy Guns Type
5.2.3.3.1.2 France Biopsy Devices Market by Biopsy Guidance Systems Type
5.2.3.3.1.3 France Biopsy Devices Market by Biopsy Needles Type
5.2.3.3.2 France Biopsy Devices Market by End User
5.2.3.4 Russia Biopsy Devices Market
5.2.3.4.1 Russia Biopsy Devices Market by Product
5.2.3.4.1.1 Russia Biopsy Devices Market by Needle-based Biopsy Guns Type
5.2.3.4.1.2 Russia Biopsy Devices Market by Biopsy Guidance Systems Type
5.2.3.4.1.3 Russia Biopsy Devices Market by Biopsy Needles Type
5.2.3.4.2 Russia Biopsy Devices Market by End User
5.2.3.5 Spain Biopsy Devices Market
5.2.3.5.1 Spain Biopsy Devices Market by Product
5.2.3.5.1.1 Spain Biopsy Devices Market by Needle-based Biopsy Guns Type
5.2.3.5.1.2 Spain Biopsy Devices Market by Biopsy Guidance Systems Type
5.2.3.5.1.3 Spain Biopsy Devices Market by Biopsy Needles Type
5.2.3.5.2 Spain Biopsy Devices Market by End User
5.2.3.6 Italy Biopsy Devices Market
5.2.3.6.1 Italy Biopsy Devices Market by Product
5.2.3.6.1.1 Italy Biopsy Devices Market by Needle-based Biopsy Guns Type
5.2.3.6.1.2 Italy Biopsy Devices Market by Biopsy Guidance Systems Type
5.2.3.6.1.3 Italy Biopsy Devices Market by Biopsy Needles Type
5.2.3.6.2 Italy Biopsy Devices Market by End User
5.2.3.7 Rest of Europe Biopsy Devices Market
5.2.3.7.1 Rest of Europe Biopsy Devices Market by Product
5.2.3.7.1.1 Rest of Europe Biopsy Devices Market by Needle-based Biopsy Guns Type
5.2.3.7.1.2 Rest of Europe Biopsy Devices Market by Biopsy Guidance Systems Type
5.2.3.7.1.3 Rest of Europe Biopsy Devices Market by Biopsy Needles Type
5.2.3.7.2 Rest of Europe Biopsy Devices Market by End User
5.3 Asia Pacific Biopsy Devices Market
5.3.1 Asia Pacific Biopsy Devices Market by Product
5.3.1.1 Asia Pacific Needle-based Biopsy Guns Market by Country
5.3.1.2 Asia Pacific Biopsy Devices Market by Needle-based Biopsy Guns Type
5.3.1.2.1 Asia Pacific Vacuum-assisted Biopsy (VAB) Devices Market by Country
5.3.1.2.2 Asia Pacific Fine Needle Aspiration Biopsy (FNAB) Devices Market by Country
5.3.1.2.3 Asia Pacific Core Needle Biopsy (CNB) Devices Market by Country
5.3.1.3 Asia Pacific Biopsy Guidance Systems Market by Country
5.3.1.4 Asia Pacific Biopsy Devices Market by Biopsy Guidance Systems Type
5.3.1.4.1 Asia Pacific Manual Market by Country
5.3.1.4.2 Asia Pacific Robotic Market by Country
5.3.1.5 Asia Pacific Biopsy Needles Market by Country
5.3.1.6 Asia Pacific Biopsy Devices Market by Biopsy Needles Type
5.3.1.6.1 Asia Pacific Disposable Market by Country
5.3.1.6.2 Asia Pacific Reusable Market by Country
5.3.1.7 Asia Pacific Biopsy Forceps Market by Country
5.3.1.8 Asia Pacific Others Market by Country
5.3.2 Asia Pacific Biopsy Devices Market by End User
5.3.2.1 Asia Pacific Hospitals Market by Country
5.3.2.2 Asia Pacific Diagnostic & Imaging Center Market by Country
5.3.2.3 Asia Pacific Others Market by Country
5.3.3 Asia Pacific Biopsy Devices Market by Country
5.3.3.1 China Biopsy Devices Market
5.3.3.1.1 China Biopsy Devices Market by Product
5.3.3.1.1.1 China Biopsy Devices Market by Needle-based Biopsy Guns Type
5.3.3.1.1.2 China Biopsy Devices Market by Biopsy Guidance Systems Type
5.3.3.1.1.3 China Biopsy Devices Market by Biopsy Needles Type
5.3.3.1.2 China Biopsy Devices Market by End User
5.3.3.2 Japan Biopsy Devices Market
5.3.3.2.1 Japan Biopsy Devices Market by Product
5.3.3.2.1.1 Japan Biopsy Devices Market by Needle-based Biopsy Guns Type
5.3.3.2.1.2 Japan Biopsy Devices Market by Biopsy Guidance Systems Type
5.3.3.2.1.3 Japan Biopsy Devices Market by Biopsy Needles Type
5.3.3.2.2 Japan Biopsy Devices Market by End User
5.3.3.3 India Biopsy Devices Market
5.3.3.3.1 India Biopsy Devices Market by Product
5.3.3.3.1.1 India Biopsy Devices Market by Needle-based Biopsy Guns Type
5.3.3.3.1.2 India Biopsy Devices Market by Biopsy Guidance Systems Type
5.3.3.3.1.3 India Biopsy Devices Market by Biopsy Needles Type
5.3.3.3.2 India Biopsy Devices Market by End User
5.3.3.4 South Korea Biopsy Devices Market
5.3.3.4.1 South Korea Biopsy Devices Market by Product
5.3.3.4.1.1 South Korea Biopsy Devices Market by Needle-based Biopsy Guns Type
5.3.3.4.1.2 South Korea Biopsy Devices Market by Biopsy Guidance Systems Type
5.3.3.4.1.3 South Korea Biopsy Devices Market by Biopsy Needles Type
5.3.3.4.2 South Korea Biopsy Devices Market by End User
5.3.3.5 Singapore Biopsy Devices Market
5.3.3.5.1 Singapore Biopsy Devices Market by Product
5.3.3.5.1.1 Singapore Biopsy Devices Market by Needle-based Biopsy Guns Type
5.3.3.5.1.2 Singapore Biopsy Devices Market by Biopsy Guidance Systems Type
5.3.3.5.1.3 Singapore Biopsy Devices Market by Biopsy Needles Type
5.3.3.5.2 Singapore Biopsy Devices Market by End User
5.3.3.6 Malaysia Biopsy Devices Market
5.3.3.6.1 Malaysia Biopsy Devices Market by Product
5.3.3.6.1.1 Malaysia Biopsy Devices Market by Needle-based Biopsy Guns Type
5.3.3.6.1.2 Malaysia Biopsy Devices Market by Biopsy Guidance Systems Type
5.3.3.6.1.3 Malaysia Biopsy Devices Market by Biopsy Needles Type
5.3.3.6.2 Malaysia Biopsy Devices Market by End User
5.3.3.7 Rest of Asia Pacific Biopsy Devices Market
5.3.3.7.1 Rest of Asia Pacific Biopsy Devices Market by Product
5.3.3.7.1.1 Rest of Asia Pacific Biopsy Devices Market by Needle-based Biopsy Guns Type
5.3.3.7.1.2 Rest of Asia Pacific Biopsy Devices Market by Biopsy Guidance Systems Type
5.3.3.7.1.3 Rest of Asia Pacific Biopsy Devices Market by Biopsy Needles Type
5.3.3.7.2 Rest of Asia Pacific Biopsy Devices Market by End User
5.4 LAMEA Biopsy Devices Market
5.4.1 LAMEA Biopsy Devices Market by Product
5.4.1.1 LAMEA Needle-based Biopsy Guns Market by Country
5.4.1.2 LAMEA Biopsy Devices Market by Needle-based Biopsy Guns Type
5.4.1.2.1 LAMEA Vacuum-assisted Biopsy (VAB) Devices Market by Country
5.4.1.2.2 LAMEA Fine Needle Aspiration Biopsy (FNAB) Devices Market by Country
5.4.1.2.3 LAMEA Core Needle Biopsy (CNB) Devices Market by Country
5.4.1.3 LAMEA Biopsy Guidance Systems Market by Country
5.4.1.4 LAMEA Biopsy Devices Market by Biopsy Guidance Systems Type
5.4.1.4.1 LAMEA Manual Market by Country
5.4.1.4.2 LAMEA Robotic Market by Country
5.4.1.5 LAMEA Biopsy Needles Market by Country
5.4.1.6 LAMEA Biopsy Devices Market by Biopsy Needles Type
5.4.1.6.1 LAMEA Disposable Market by Country
5.4.1.6.2 LAMEA Reusable Market by Country
5.4.1.7 LAMEA Biopsy Forceps Market by Country
5.4.1.8 LAMEA Others Market by Country
5.4.2 LAMEA Biopsy Devices Market by End User
5.4.2.1 LAMEA Hospitals Market by Country
5.4.2.2 LAMEA Diagnostic & Imaging Center Market by Country
5.4.2.3 LAMEA Others Market by Country
5.4.3 LAMEA Biopsy Devices Market by Country
5.4.3.1 Brazil Biopsy Devices Market
5.4.3.1.1 Brazil Biopsy Devices Market by Product
5.4.3.1.1.1 Brazil Biopsy Devices Market by Needle-based Biopsy Guns Type
5.4.3.1.1.2 Brazil Biopsy Devices Market by Biopsy Guidance Systems Type
5.4.3.1.1.3 Brazil Biopsy Devices Market by Biopsy Needles Type
5.4.3.1.2 Brazil Biopsy Devices Market by End User
5.4.3.2 Argentina Biopsy Devices Market
5.4.3.2.1 Argentina Biopsy Devices Market by Product
5.4.3.2.1.1 Argentina Biopsy Devices Market by Needle-based Biopsy Guns Type
5.4.3.2.1.2 Argentina Biopsy Devices Market by Biopsy Guidance Systems Type
5.4.3.2.1.3 Argentina Biopsy Devices Market by Biopsy Needles Type
5.4.3.2.2 Argentina Biopsy Devices Market by End User
5.4.3.3 UAE Biopsy Devices Market
5.4.3.3.1 UAE Biopsy Devices Market by Product
5.4.3.3.1.1 UAE Biopsy Devices Market by Needle-based Biopsy Guns Type
5.4.3.3.1.2 UAE Biopsy Devices Market by Biopsy Guidance Systems Type
5.4.3.3.1.3 UAE Biopsy Devices Market by Biopsy Needles Type
5.4.3.3.2 UAE Biopsy Devices Market by End User
5.4.3.4 Saudi Arabia Biopsy Devices Market
5.4.3.4.1 Saudi Arabia Biopsy Devices Market by Product
5.4.3.4.1.1 Saudi Arabia Biopsy Devices Market by Needle-based Biopsy Guns Type
5.4.3.4.1.2 Saudi Arabia Biopsy Devices Market by Biopsy Guidance Systems Type
5.4.3.4.1.3 Saudi Arabia Biopsy Devices Market by Biopsy Needles Type
5.4.3.4.2 Saudi Arabia Biopsy Devices Market by End User
5.4.3.5 South Africa Biopsy Devices Market
5.4.3.5.1 South Africa Biopsy Devices Market by Product
5.4.3.5.1.1 South Africa Biopsy Devices Market by Needle-based Biopsy Guns Type
5.4.3.5.1.2 South Africa Biopsy Devices Market by Biopsy Guidance Systems Type
5.4.3.5.1.3 South Africa Biopsy Devices Market by Biopsy Needles Type
5.4.3.5.2 South Africa Biopsy Devices Market by End User
5.4.3.6 Nigeria Biopsy Devices Market
5.4.3.6.1 Nigeria Biopsy Devices Market by Product
5.4.3.6.1.1 Nigeria Biopsy Devices Market by Needle-based Biopsy Guns Type
5.4.3.6.1.2 Nigeria Biopsy Devices Market by Biopsy Guidance Systems Type
5.4.3.6.1.3 Nigeria Biopsy Devices Market by Biopsy Needles Type
5.4.3.6.2 Nigeria Biopsy Devices Market by End User
5.4.3.7 Rest of LAMEA Biopsy Devices Market
5.4.3.7.1 Rest of LAMEA Biopsy Devices Market by Product
5.4.3.7.1.1 Rest of LAMEA Biopsy Devices Market by Needle-based Biopsy Guns Type
5.4.3.7.1.2 Rest of LAMEA Biopsy Devices Market by Biopsy Guidance Systems Type
5.4.3.7.1.3 Rest of LAMEA Biopsy Devices Market by Biopsy Needles Type
5.4.3.7.2 Rest of LAMEA Biopsy Devices Market by End User
Chapter 6. Company Profiles
6.1 Medtronic PLC
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 SWOT Analysis
6.2 Hologic, Inc
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Fujifilm Holdings Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 B. Braun Melsungen AG
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Danaher Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 ConMed Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Becton, Dickinson and Company
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Cardinal Health, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Argon Medical Devices, Inc.
6.9.1 Company Overview
6.10. Cook Medical, Inc. (Cook Group)
6.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Hologic, Inc.
- Fujifilm Holdings Corporation
- B. Braun Melsungen AG
- Danaher Corporation
- ConMed Corporation
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Argon Medical Devices, Inc.
- Cook Medical, Inc.
Methodology
LOADING...
